This study presents the analysis of peroxidation and antioxidation system in patients with combination of ischemic heart disease and rheumatism (100 patients with combined pathology and 50 with ischemic heart disease). This measurement was predictable — numbers really differ in these two pathologies. Patients with combined pathology have more severe symptoms. That leads to more significant risk of coronary disease in this group.
Using of MMW and DMW in combination with SMT-phoresis on the hepar-area with the biological rhymes using leads to better numbers of peroxidation and antioxidation system in patients with combination of ischemic heart disease and rheumatism.